|
Re: Precedence in Gene Therapy Pricing
|
3
|
Resverlogix Corp.
|
Jan 03, 2018 12:43PM
|
|
Re: Next Hurdle
|
3
|
Resverlogix Corp.
|
Jan 05, 2018 12:12PM
|
|
Re: Next Hurdle
|
3
|
Resverlogix Corp.
|
Jan 05, 2018 01:14PM
|
|
Re: Next Hurdle
|
1
|
Resverlogix Corp.
|
Jan 05, 2018 01:21PM
|
|
Re: Any word on today's presentation?
|
|
Resverlogix Corp.
|
Jan 08, 2018 04:42PM
|
|
Re: Presentations
|
2
|
Resverlogix Corp.
|
Jan 09, 2018 10:05AM
|
|
Re: ANYTHING ON THE SHOWCASE?
|
2
|
Zenith Epigenetics
|
Jan 09, 2018 10:11AM
|
|
Re: Presentations-FYI...
|
1
|
Resverlogix Corp.
|
Jan 09, 2018 12:14PM
|
|
Re: Presentations-FYI...
|
1
|
Resverlogix Corp.
|
Jan 09, 2018 12:45PM
|
|
Re: Presentation is up
|
2
|
Zenith Epigenetics
|
Jan 09, 2018 02:28PM
|
|
Re: Presentation is Up
|
1
|
Resverlogix Corp.
|
Jan 09, 2018 02:29PM
|
|
Re: ...new publication just tweeted out> ... link
|
3
|
Resverlogix Corp.
|
Jan 09, 2018 04:51PM
|
|
Re: Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
|
8
|
Resverlogix Corp.
|
Jan 11, 2018 02:29PM
|
|
Re: BETonMACE Enrollment
|
6
|
Resverlogix Corp.
|
Jan 11, 2018 03:01PM
|
|
Re: Awaken Dormant DNA, Epigenetically - Article in GEN
|
1
|
Zenith Epigenetics
|
Jan 13, 2018 11:23PM
|
|
Re: CANTOS and CIRT
|
6
|
Resverlogix Corp.
|
Jan 15, 2018 12:27PM
|
|
Re: BETonMACE top line data
|
6
|
Resverlogix Corp.
|
Jan 16, 2018 12:22PM
|
|
Re: BETonMACE top line data
|
|
Resverlogix Corp.
|
Jan 16, 2018 12:53PM
|
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 16, 2018 01:57PM
|
|
Re: BETonMACE top line data
|
|
Resverlogix Corp.
|
Jan 16, 2018 05:13PM
|
